Navigation Links
Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
Date:8/19/2007

bal development and commercialization agreement.

For additional information on Kosan Biosciences, please visit the Company's website at http://www.kosan.com.

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 (the "Act"). Such forward-looking statements include but are not limited to statements related to the further development and potential safety, efficacy, commercialization and other characteristics of tanespimycin or tanespimycin injectable suspension, Kosan's development plans with respect to tanespimycin, including but not limited to Kosan's plans and timing for the initiation of TIME-2, TIME-2 as a potential registration trial, and potential accelerated registration strategy for tanespimycin. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. There are a number of important factors that could cause the results of Kosan to differ materially from those indicated by these forward-looking statements, including, among others, risks related to the development of tanespimycin, including the risk that studies may not demonstrate safety and efficacy sufficient to initiate additional clinical trials, continue clinical development on the timing currently anticipated or at all, obtain the requisite regulatory approvals or result in a marketable product; and other risks detailed from time to time in the Kosan's SEC reports, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2007 and other periodic filings with the SEC. Kosan does not undertake any obligation to update forward-looking statements.

Velcade(R) (bortezomib) is a registered trademark of Millennium

Pharmaceuticals, Inc.

Herceptin(R) (trastuzumab) is a registered trademark of Genentech, Inc.

Revlimid(R) (lena
'/>"/>

SOURCE Kosan Biosciences Incorporated

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
3. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
4. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
5. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
6. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
7. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
8. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
9. Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
10. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
11. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... , TAINAN, Taiwan, Nov. 19 /PRNewswire-Asi...ive pharmaceutical ingredients (APIs), announced t...mpound Safety Certification from,SafeBridge(R) Con...rm,s,competency and proficiency in the safe handli...Is), and applies to specific laboratories and,prod...
(Date:11/19/2009)... , ABBOTT PARK, Ill., Nov. 19 /PRNewswire-First...(NYSE: ABT ) as one of its Most Admired Corporat...e Deal honored Abbott as its Most Admired Dealmak...gic use of acquisitions and divestitures since Jan...reshaped its business portfolio with a focus on hi...
(Date:11/19/2009)... , Part of International Internet Week of Ac...e-USNewswire/ -- The U.S. Food and Drug Administra...rnational effort, called the International Interne...actions involving medical products. ,, (Logo: ...GO ) ,, During the effort, the FDA,s Office of ...
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Panel assesses evidence for the collection and use of family health history information 55523 1Panel assesses evidence for the collection and use of family health history information 55523 2Panel assesses evidence for the collection and use of family health history information 55523 3105th APSA Meeting worlds largest for the study of politics will be in Toronto Sept 3 6 55520 1105th APSA Meeting worlds largest for the study of politics will be in Toronto Sept 3 6 55520 2Beta blockers and stroke new insights into their use for older people 9715 1Beta blockers and stroke new insights into their use for older people 9715 2
(Date:11/21/2009)... , NEW YORK, Nov. 21 Milvia ... New York City, recently filed suit, in Supreme Co... The complaint alleges that while Ms. Lopez underw...") at ST. VINCENT,S HOSPITAL , doctors used an HI...complaint alleges that several hours after being d...
(Date:11/21/2009)... Innovative medical apparel ...nference , San Clemente, ... maker of breakthrough medical apparel, today anno... on display at Medica 2009, a leading internationa...eldorf, Germany. Medelita inaugurates its men,s co...
(Date:11/20/2009)... , Pioneering Neurologist Closer to Understan...ov. 20 Dr. Jeremy Schma...chool and neurologist at the Massachusetts General...sented his laboratory,s research on the new field ...e MINDlink Foundation. ,, Dr. Schmahmann is an ...
(Date:11/20/2009)... Senators and Congressmen in...le Over their Health Care Vote , ...- Senators and congressmen running for re-election...litical guru Charlie Cook, may come to regret voti...are bill, according to a breaking Zogby Internatio...
(Date:11/20/2009)... , WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-U...e is on a mission to redefine what it means to be ...ional counselor with a specialty in family counsel...ake Forest University, Gladding says research show...eads to sadness and even depression during the hol...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2
...irst time how microscopic crystals form sound and ...he ends of cilia tiny cellular hairs in the ear t... an important role in detecting sound, maintaining... vertigo, the disorder plagues up to 10 percent of...
...e Corporation,(Pink Sheets: MNCN), a biological so...e a positive long term benefit to the agricultural... Ballantyne will join the Company,s Board,of Direc...f a number of public and,private companies and is ...
...vent the spread of germs and,protect its patients ...wo new,products that kill germs on hands and surfa...ion Prevention Director LeAnna Grace, the hospital...by the,results. , "At Rome Memorial Hospital...
...nesis, Inc., a leading,regenerative medicine compa...igious awards honoring the company,s cutting edge ... Organogenesis, manufacturing division has bee...n the magazine,s upcoming,December 2008 issue. Ad...
...a is pleased to announce it,has reached an agreeme...ading,pharmaceutical companies, to dispense the co...sta,s no-cost prescription medication program. Wi...uninsured. Including sanofi-aventis, Welvista now ...
...nd bone damage that could develop into early osteo...ws) -- Young gymnasts now appear to be developing ...new study says. , Injuries to gymnasts, bones --... of the bones of the knuckles has been found, acco...
Other Medicine News:Health News:Can you hear me now? How the inner ear's sensors are made 2Health News:Mr. Tad Ballantyne to Join Mach One Board of Directors 2Health News:MRSA and C. difficile Infections Reduced by 50% in Hospital Study 2Health News:MRSA and C. difficile Infections Reduced by 50% in Hospital Study 3Health News:Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence 2Health News:Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence 3Health News:Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence 4Health News:Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured 2Health News:Young Gymnasts Facing Broad Range of New Injuries 2
Full-Height Radiation Barriers
Mobile Protective Shield
Center Mounted Barriers
ECONO GUARD
Medicine Products: